Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy Hamel

Showing results (31-40 of 70) with videos related to

Pageof 7
Sort By:
Journal of Medical Genetics|March 31, 2026
<i>ATM</i> c.7374_7375insAlu is a French-Canadian founder pathogenic variant associated with predisposition to pancreatic and breast cancerYifan Wang, Celine Domecq, Adeline Cuggia, et al.
Cancer Research|February 12, 2004
The prognostic implication of the basal-like (cyclin E high/p27 low/p53+/glomeruloid-microvascular-proliferation+) phenotype of BRCA1-related breast cancerWilliam D Foulkes, Jean-Sébastien Brunet, Ingunn M Stefansson, et al.
Breast Cancer Research : BCR|December 7, 2007
Identification of a novel truncating PALB2 mutation and analysis of its contribution to early-onset breast cancer in French-Canadian womenWilliam D Foulkes, Parviz Ghadirian, Mohammed Reza Akbari, et al.
American Journal of Human Genetics|October 31, 2025
Using the ancestral recombination graph to study the history of rare variants in founder populationsAlejandro Mejia-Garcia, Alex Diaz-Papkovich, Guillaume Sillon, et al.
The New England Journal of Medicine|December 31, 2010
Homozygous BUB1B mutation and susceptibility to gastrointestinal neoplasiaThomas Rio Frio, Josée Lavoie, Nancy Hamel, et al.
Acta Neuropathologica|March 1, 2021
Molecular characterization of DICER1-mutated pituitary blastomaJavad Nadaf, Leanne de Kock, Anne-Sophie Chong, et al.
Human Mutation|October 2, 2009
Functional redundancy of exon 12 of BRCA2 revealed by a comprehensive analysis of the c.6853A>G (p.I2285V) variantLili Li, Kajal Biswas, Laura Anne Habib, et al.
Clinical Genetics|June 23, 2025
PMS2 c.2117del (p.Lys706Serfs*19) is the Most Frequent Cancer-Associated Founder Pathogenic Variant in the French-Canadian Population of Quebec, CanadaAnne-Laure Chong, Alejandro Mejia-Garcia, Supriya Behl, et al.
The Journal of Allergy and Clinical Immunology|November 2, 2015
Impaired RASGRF1/ERK-mediated GM-CSF response characterizes CARD9 deficiency in French-CanadiansChristina Gavino, Nancy Hamel, Ji Bin Zeng, et al.
JCO Precision Oncology|June 8, 2026
Asynchronous Contralateral Primaries of Small Cell Carcinoma of the Ovary, Hypercalcemic Type in Germline <i>SMARCA4</i> Pathogenic Variant CarriersBen L Kong, Brett E Johnson, Julian Egger, et al.
Pageof 7

Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
Journal of Medical Genetics|March 31, 2026
<i>ATM</i> c.7374_7375insAlu is a French-Canadian founder pathogenic variant associated with predisposition to pancreatic and breast cancerYifan Wang, Celine Domecq, Adeline Cuggia, et al.
Cancer Research|February 12, 2004
The prognostic implication of the basal-like (cyclin E high/p27 low/p53+/glomeruloid-microvascular-proliferation+) phenotype of BRCA1-related breast cancerWilliam D Foulkes, Jean-Sébastien Brunet, Ingunn M Stefansson, et al.
Breast Cancer Research : BCR|December 7, 2007
Identification of a novel truncating PALB2 mutation and analysis of its contribution to early-onset breast cancer in French-Canadian womenWilliam D Foulkes, Parviz Ghadirian, Mohammed Reza Akbari, et al.
American Journal of Human Genetics|October 31, 2025
Using the ancestral recombination graph to study the history of rare variants in founder populationsAlejandro Mejia-Garcia, Alex Diaz-Papkovich, Guillaume Sillon, et al.
The New England Journal of Medicine|December 31, 2010
Homozygous BUB1B mutation and susceptibility to gastrointestinal neoplasiaThomas Rio Frio, Josée Lavoie, Nancy Hamel, et al.
Acta Neuropathologica|March 1, 2021
Molecular characterization of DICER1-mutated pituitary blastomaJavad Nadaf, Leanne de Kock, Anne-Sophie Chong, et al.
Human Mutation|October 2, 2009
Functional redundancy of exon 12 of BRCA2 revealed by a comprehensive analysis of the c.6853A>G (p.I2285V) variantLili Li, Kajal Biswas, Laura Anne Habib, et al.
Clinical Genetics|June 23, 2025
PMS2 c.2117del (p.Lys706Serfs*19) is the Most Frequent Cancer-Associated Founder Pathogenic Variant in the French-Canadian Population of Quebec, CanadaAnne-Laure Chong, Alejandro Mejia-Garcia, Supriya Behl, et al.
The Journal of Allergy and Clinical Immunology|November 2, 2015
Impaired RASGRF1/ERK-mediated GM-CSF response characterizes CARD9 deficiency in French-CanadiansChristina Gavino, Nancy Hamel, Ji Bin Zeng, et al.
JCO Precision Oncology|June 8, 2026
Asynchronous Contralateral Primaries of Small Cell Carcinoma of the Ovary, Hypercalcemic Type in Germline <i>SMARCA4</i> Pathogenic Variant CarriersBen L Kong, Brett E Johnson, Julian Egger, et al.
Pageof 7